Pharmacy OneSource Blog

Sentri7 Earns KLAS Category Leader Designation for Clinical Decision Support-Surveillance

Posted on 01/29/16

KLAS_logo-1

Clinical decision support (CDS) surveillance systems have earned their place in today’s healthcare environments as a critical component of proactive, quality-driven healthcare. At Wolters Kluwer, we see the positive impact these solutions have on care delivery every day as we continue leading the charge to equip clinicians with the real-time knowledge needed to streamline operational workflows and drive outcomes improvement.

That is why we are honored by the recognition of Sentri7® as the Category Leader for Clinical Decision Support-Surveillance in the 2015/2016 Best in KLAS: Software & Services report – a recognition made possible by the willingness of our customers to share with KLAS their positive experiences about our solution. This marks the second time that our real-time clinical surveillance and decision support software has earned the Category Leader designation. It topped the same category in the 2013 survey, which ranks the best-performing healthcare IT vendors in more than 100 market segments based on the aggregated experiences of thousands of healthcare providers.

David A. Del Toro, President & CEO of Clinical Software Solutions at Wolters Kluwer, recently noted that, “We designed Sentri7 to help hospitals achieve the over-arching objectives of higher quality, lower cost care, and to help clinicians by speeding identification of risk and treatment decisions. We are honored to have our customers once again acknowledge through KLAS the role Sentri7 plays in helping them achieve these objectives.”

Backed by the powerhouse Wolters Kluwer CDS offerings of UpToDate and Clinical Drug Information, hospitals and health systems across the U.S. are leveraging Sentri7 to address such high-level initiatives as medication management and safety, infection prevention and antimicrobial stewardship. The results of using Sentri7 speak for themselves:

  • In less than two months of deploying Sentri7, Carteret General Hospital tracked monthly cost avoidance numbers equating to $3.2 million to $4.2 million a year. 
  • In three years, Texas Health Arlington Memorial saw a 750% increase in antimicrobial-related activities and a 35% decrease in antibiotic costs per patient day. 
  • Every hour, Sentri7 hospitals save $246,862 in total costs as a result of pharmacy interventions alone. That’s more than $720 million each year.
  • Every hour, Sentri7 processes 35,000 rules and documents more than 4,000 interventions. On an annual basis, that translates to more than 12 million interventions that improve care.

Leading research firm KLAS enables providers to make more-informed technology decisions and helps vendors strive for excellence. An independent healthcare IT vendor research firm, KLAS publishes the annual Best in KLAS report to provide healthcare organizations with an unbiased and accurate vehicle for measuring performance in the healthcare industry, allowing for further understanding of how well suppliers and products perform. 

Wolters Kluwer applauds the Sentri7 team and our hospital and health system partners in the industry. Together, we are elevating care delivery, lowering costs, and saving lives.

Topics: Clinical Surveillance

About the Author

Deb Oroszlan is the Marketing Director for Pharmacy OneSource - Wolters Kluwer.